Grace Therapeutics, Inc. (GRCE) Operating margin 2022–2023
Grace Therapeutics, Inc. (GRCE) operating margin by fiscal year — reported operating income divided by reported revenue.
-52.2%FY2023 · since FY2022: -7953.6% → -52.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -52.2% | +7901.4 pp |
| FY2022 | -7953.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More GRCE financial trends
GRCE RevenueGRCE Net incomeGRCE Net marginGRCE Gross profitGRCE Gross marginGRCE Operating incomeGRCE Operating cash flowGRCE Free cash flowGRCE Capital expendituresGRCE Return on equityGRCE Stock buybacksGRCE Dividends paidGRCE Total assetsGRCE Total liabilitiesGRCE Shareholders’ equityGRCE overview →